Clinical trials
Observational Leukemia, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 5 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Arkansas Children's Hospital Research Institute | 1 |
| Asfendiyarov Kazakh National Medical University | 1 |
| Astellas Pharma International B.V. | 1 |
| Bristol-Myers Squibb | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Genzyme, a Sanofi Company | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 22 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Multiple Myeloma | 4 |
| Lymphoma | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Burkitt Lymphoma | 1 |
| Hematologic Neoplasms | 1 |
| Hyperplasia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.